1. Ghobadi, Mohadeseh Zarei, Afsaneh, Elaheh, Emamzadeh, Rahman, Soroush, Mona. 2023. Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus. In BMC medical genomics, 16, 62. doi:10.1186/s12920-023-01492-0. https://pubmed.ncbi.nlm.nih.gov/36978083/
2. Hunter, Francis W, Jaiswal, Jagdish K, Hurley, Daniel G, Wilson, William R, Pruijn, Frederik B. 2014. The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs. In Biochemical pharmacology, 89, 224-35. doi:10.1016/j.bcp.2014.03.001. https://pubmed.ncbi.nlm.nih.gov/24632291/
3. Ogunbawo, Adebisi R, Mulim, Henrique A, Campos, Gabriel S, Oliveira, Hinayah R. 2024. Genetic Foundations of Nellore Traits: A Gene Prioritization and Functional Analyses of Genome-Wide Association Study Results. In Genes, 15, . doi:10.3390/genes15091131. https://pubmed.ncbi.nlm.nih.gov/39336722/
4. Wang, Sha, Wang, Xia, Chen, Jing, Wang, Min, Zhang, Chi. 2024. Identification of key genes and biological pathways associated with vascular aging in diabetes based on bioinformatics and machine learning. In Aging, 16, 9369-9385. doi:10.18632/aging.205870. https://pubmed.ncbi.nlm.nih.gov/38809515/
5. Mir, Rashid, Altemani, Faisal H, Algehainy, Naseh A, Alhiwety, Mohammed Saad, Ullah, Mohammad Fahad. 2024. Identification of Novel Genomic Variants in COVID-19 Patients Using Whole-Exome Sequencing: Exploring the Plausible Targets of Functional Genomics. In Biochemical genetics, , . doi:10.1007/s10528-024-10970-8. https://pubmed.ncbi.nlm.nih.gov/39557769/
6. Liu, Xue, Song, Jing, Liu, Hui, Ren, Huiwen, Luo, Judong. 2023. Endoplasmic Reticulum Stress Could Predict the Prognosis of Cervical Cancer and Regulate the Occurrence of Radiation Mucositis. In Dose-response : a publication of International Hormesis Society, 21, 15593258231173199. doi:10.1177/15593258231173199. https://pubmed.ncbi.nlm.nih.gov/37197387/
7. Nagy, Ádám, Pongor, Lőrinc Sándor, Szabó, András, Santarpia, Mariacarmela, Győrffy, Balázs. 2016. KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer. In International journal of cancer, 140, 930-937. doi:10.1002/ijc.30509. https://pubmed.ncbi.nlm.nih.gov/27859136/